Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible

被引：0
|
作者：
Richard E. Gilbert
Kim A. Connelly
机构：
[1] St. Michael’s Hospital,Division of Endocrinology
[2] St. Michael’s Hospital,Division of Cardiology
来源：
Cardiovascular Diabetology | / 18卷
关键词：
Sodium–glucose linked cotransporter-2; Myocardial infarction; Cardiovascular outcome trials; Stroke;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives
    Mondal, Sunetra
    Pramanik, Subhodip
    Khare, Vibhu Ranjan
    Fernandez, Cornelius James
    Pappachan, Joseph M.
    WORLD JOURNAL OF CARDIOLOGY, 2024, 16 (05): : 240 - 259
  • [22] Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2
    Chen, Sha
    Wang, Qian
    Christodoulou, Andriana
    Mylonas, Nikolaos
    Bakker, Diane
    Nederlof, Rianne
    Hollmann, Markus W.
    Weber, Nina C.
    Coronel, Ruben
    Wakker, Vincent
    Christoffels, Vincent M.
    Andreadou, Ioanna
    Zuurbier, Coert J.
    CIRCULATION, 2023, 147 (03) : 276 - 279
  • [23] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Mckenzie, Taylor
    Hale, Genevieve M.
    Miner, Amelia
    Colon, Jean Colon
    Evins, Garrett
    Wade, Jasmine
    HEART FAILURE REVIEWS, 2024, 29 (02) : 549 - 558
  • [24] Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections
    Sarafidis, Pantelis
    Papagianni, Aikaterini
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (12) : 943 - 944
  • [25] Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
    Yang Fan
    Meng Ran
    Zhu Da-Long
    慢性疾病与转化医学（英文）, 2020, 06 (04) : 239 - 245
  • [26] Expanding Clinical Use of Sodium-glucose Cotransporter-2 Inhibitors?
    Dhawan, Richa
    Chaney, Mark A.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (10) : 2135 - 2138
  • [27] Sodium-glucose cotransporter-2 inhibitors in patients without diabetes
    Fryml, Elise
    Lanktree, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (17) : E619 - E619
  • [28] Sodium-glucose cotransporter-2 inhibitors reduce the risk of gout
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (02): : 190 - 191
  • [29] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Taylor McKenzie
    Genevieve M. Hale
    Amelia Miner
    Jean Colón Colón
    Garrett Evins
    Jasmine Wade
    Heart Failure Reviews, 2024, 29 : 549 - 558
  • [30] The impact of sodium-glucose cotransporter-2 inhibitors on cardiac function
    Chen, I-Wen
    Weng, Hsiu-Lan
    Hung, Kuo-Chuan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 130 - 131
12345